0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.52%
Negative revenue growth while 0425.HK stands at 22.85%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.64%
Negative gross profit growth while 0425.HK is at 21.01%. Joel Greenblatt would examine cost competitiveness or demand decline.
-43.49%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-40.57%
Negative operating income growth while 0425.HK is at 11.64%. Joel Greenblatt would press for urgent turnaround measures.
-82.23%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-80.89%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-82.21%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-7.43%
Share reduction while 0425.HK is at 1.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.01%
Diluted share reduction more than 1.5x 0425.HK's 1.34%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
364.22%
OCF growth above 1.5x 0425.HK's 86.29%. David Dodd would confirm a clear edge in underlying cash generation.
237.08%
FCF growth above 1.5x 0425.HK's 24.89%. David Dodd would verify if the firm’s strategic investments yield superior returns.
75929.25%
10Y revenue/share CAGR above 1.5x 0425.HK's 1328.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
33.05%
5Y revenue/share CAGR under 50% of 0425.HK's 167.98%. Michael Burry would suspect a significant competitive gap or product weakness.
4.30%
3Y revenue/share CAGR under 50% of 0425.HK's 53.71%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2432.89%
10Y OCF/share CAGR above 1.5x 0425.HK's 1508.39%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-19.33%
Negative 5Y OCF/share CAGR while 0425.HK is at 24.50%. Joel Greenblatt would question the firm’s operational model or cost structure.
78.77%
Positive 3Y OCF/share CAGR while 0425.HK is negative. John Neff might see a big short-term edge in operational efficiency.
170.51%
Below 50% of 0425.HK's 612.11%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
118.16%
5Y net income/share CAGR 1.25-1.5x 0425.HK's 100.03%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
158.20%
3Y net income/share CAGR above 1.5x 0425.HK's 12.41%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
240.50%
5Y equity/share CAGR above 1.5x 0425.HK's 97.64%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
102.05%
3Y equity/share CAGR above 1.5x 0425.HK's 32.90%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0425.HK stands at 66.19%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
No Data
No Data available this quarter, please select a different quarter.
72.56%
Inventory growth well above 0425.HK's 27.33%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.91%
Negative asset growth while 0425.HK invests at 7.40%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
9.36%
1.25-1.5x 0425.HK's 6.65%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
24.71%
We have some new debt while 0425.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-71.23%
Our R&D shrinks while 0425.HK invests at 22.12%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.54%
SG&A declining or stable vs. 0425.HK's 35.84%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.